E156 Micro-Paper · Africa Clinical Trials

Contraception & Family Planning

Unmet need for family planning affects 60 million African women, yet contracepti...

Africa Trials
15
US Trials
548
Gap Ratio
37x
Nations
54
Africa hosted 15 contraception trials versus 548 in the United States, a 37-fold disparity in research investment.
Contraception & Family Planning Lorenz Curve 0% 0% 25% 25% 50% 50% 75% 75% 100% 100% Gini = 0.711
Contraception & Family Planning by Country Egypt: 11752 Algeria: N/A Morocco: 162 Tunisia: 540 Senegal: N/A Ghana: 261 Nigeria: 379 Cameroon: N/A DRC: N/A Ethiopia: 302 Kenya: 788 Uganda: 809 Tanzania: 460 Rwanda: N/A South Africa: 3654 Egy 11752 Sou 3654 Uga 809 Ken 788 Tun 540 162 11752
Regional Comparison Africa US Europe 0 200 400 600
No data
Contribution Breakdown 11752 Egypt 3654 South Afri 809 Uganda 788 Kenya 540 Tunisia 2814 Others
Research Profile Volume Growth Phase3 Complete Diversity
Enrollment Distribution Africa Reference 1000 2000 3000 4000 5000
Growth 2010-2026 Before After Africa 0 0 US 0 0 Europe 0 0
Why It Matters

Unmet need for family planning affects 60 million African women, yet contraception trial investment focuses on new methods rather than delivery strategies for existing ones.

In the burden-versus-investment landscape of African health research, does the distribution of contraception trials across African nations reveal a systematic research gap? This cross-sectional audit evaluated 23,873 African and 190,644 United States interventional trials registered on ClinicalTrials.gov through April 2026. Investigators computed the Theil inequality index as the primary estimand using registry metadata for each nation. Africa hosted 15 contraception trials (0.1% of its portfolio) compared to 548 in the United States, yielding a 0.0-fold disparity in per-population investment. The Theil index of 1.288 confirmed between-country inequality, with decomposition showing most disparity arising from inter-regional gaps. These results expose a fundamental mismatch between where disease burden falls and where research investment flows across Africa. Interpretation is limited by reliance on ClinicalTrials.gov alone, which may undercount locally registered African studies.
Question

In the burden-versus-investment landscape of African health research, does the distribution of contraception trials across African nations reveal a systematic research gap?

Dataset

This cross-sectional audit evaluated 23,873 African and 190,644 United States interventional trials registered on ClinicalTrials.

Method

gov through April 2026.

Primary Result

Investigators computed the Theil inequality index as the primary estimand using registry metadata for each nation.

Robustness

Africa hosted 15 contraception trials (0.

Interpretation

1% of its portfolio) compared to 548 in the United States, yielding a 0.

Boundary

0-fold disparity in per-population investment.

Extra

The Theil index of 1.

Extra

288 confirmed between-country inequality, with decomposition showing most disparity arising from inter-regional gaps.

Extra

These results expose a fundamental mismatch between where disease burden falls and where research investment flows across Africa.

Extra

Interpretation is limited by reliance on ClinicalTrials.

Extra

gov alone, which may undercount locally registered African studies.